APA (7th ed.) Citation

G, C., BAC, C., SL, H., & SE, B. (2026). Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence". Annals of neurology, 99(6), 1614. https://doi.org/10.1002/ana.78222

Chicago Style (17th ed.) Citation

G, Cerono, Cree BAC, Hauser SL, and Baranzini SE. "Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence"." Annals of Neurology 99, no. 6 (2026): 1614. https://doi.org/10.1002/ana.78222.

MLA (9th ed.) Citation

G, Cerono, et al. "Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence"." Annals of Neurology, vol. 99, no. 6, 2026, p. 1614, https://doi.org/10.1002/ana.78222.